Dr. Charles Louis Wiseman, MD
- Part D claims, 2020
- 11
- Publications
- 22
- Clinical trials
- 2
- Industry payments
- $1,246
- State licenses
- 4
- Practice address
- 400 W Mineral King Ave, Visalia, CA 93291
- Practice phone
- Call (323) 377-4741
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Wiseman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Charles Louis Wiseman is a medical oncologist in Visalia, California
Dr. Wiseman practices in Visalia, California.
Dr. Wiseman's NPI, 1962493551, was assigned on November 2, 2005. Dr. Wiseman graduated from David Geffen School of Medicine at UCLA in 1969. Dr. Wiseman holds California license A24132.
- NPI
- 1962493551NPI Registry (opens in a new tab)
- NPI enumeration date
- November 2, 2005
- NPI status
- Active
- Practice phone
- (323) 377-4741
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1969
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Charles Louis Wiseman's practice address is in Visalia, California
Dr. Wiseman's practice address in the NPI Registry is 400 W Mineral King Ave, Visalia, CA 93291, in Tulare County. The practice phone is (323) 377-4741.
- NPI Registry address400 W Mineral King Ave, Visalia, CA 93291 · Tulare CountyPhone(323) 377-4741
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Charles Louis Wiseman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wiseman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Wiseman's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Charles Louis Wiseman is one of 415 medical oncologists in California
Medical oncology is Dr. Wiseman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Wiseman's licenses on file in 4 states: California, Florida, Texas and Louisiana.
Specialties and state licenses
- Medical oncology, CaliforniaPrimary
- Florida license
- Texas license
- Louisiana license
Medical oncologists near Dr. Wiseman
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Charles Louis Wiseman wrote 11 Medicare Part D claims in 2020
In 2020, Dr. Wiseman wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $22,249 in total drug cost. In 2019, CMS named 63 claims across 5 drugs.
Dr. Wiseman's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 632020: 1183%
Drugs named by CMS: 1 in 2020, 5 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Charles Louis Wiseman has 22 publications on record
Dmand AI links 22 papers to Dr. Wiseman, published from 2003 to 2018. The most frequent topics are Breast Neoplasms, Drug Evaluation and Antineoplastic Agents. Dr. Wiseman has published most often in Cancer. Dr. Wiseman's most frequent co-authors are Cary A. Presant, MD, Douglas W. Blayney, MD and George R. Blumenschein, MD.
Topics Dr. Wiseman writes about most
- Breast Neoplasms
- Drug Evaluation
- Antineoplastic Agents
- Cancer Vaccines
- Doxorubicin
- Granulocyte-Macrophage Colony-Stimulating Factor
- Nausea
- Neoplasm Metastasis
Dr. Wiseman's most frequent co-authors
- Cary A. Presant, MD7 shared papers
- Douglas W. Blayney, MD6 shared papers
- George R. Blumenschein, MD4 shared papers
Recent publications by Dr. Wiseman
A validated mathematical model of cell-mediated immune response to tumor growth (opens in a new tab)
Cancer Res
J Natl Cancer Inst
See who Dr. Wiseman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wiseman works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Charles Louis Wiseman has worked on 2 clinical trials
Dmand AI links Dr. Wiseman to 2 clinical trials. Conditions studied include Breast Neoplasms, Male, Mesothelioma, Malignant and Breast Neoplasms.
Clinical trials with Dr. Wiseman by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Wiseman's trials
- Breast Neoplasms, Male
- Mesothelioma, Malignant
- Breast Neoplasms
- Pleural Neoplasms
Recent clinical trials with Dr. Wiseman
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers (opens in a new tab)
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Charles Louis Wiseman received $1,246 in industry payments from 2016 to 2020
CMS Open Payments shows 55 general payments to Dr. Wiseman from 14 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $443.
General payments to Dr. Wiseman by program year, 2016 to 2020
Companies that paid Dr. Wiseman the most, 2016 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Charles Louis Wiseman has 1 award and honors on record
Dmand AI lists 1 award for Dr. Wiseman, most recently Founder and Director in 2016.
Awards and honors for Dr. Wiseman
- 2016
- Founder and Director
Source: Dmand AI Professional Profile Data
Dr. Charles Louis Wiseman graduated from David Geffen School of Medicine at UCLA
Dr. Wiseman graduated from David Geffen School of Medicine at UCLA in 1969.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Charles Louis Wiseman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Charles Louis Wiseman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Charles Louis Wiseman's NPI number?
Dr. Charles Louis Wiseman's NPI number is 1962493551. It was assigned on November 2, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Charles Louis Wiseman?
Dr. Charles Louis Wiseman is a medical oncologist in Visalia, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Charles Louis Wiseman practice?
Dr. Wiseman practices at 400 W Mineral King Ave, Visalia, CA 93291.
What is Dr. Charles Louis Wiseman's office phone number?
The practice phone on file for Dr. Wiseman is (323) 377-4741.
What is Dr. Charles Louis Wiseman's medical license number?
Dr. Wiseman holds California license A24132, one of the licenses on file in 4 states.
Which states has Dr. Charles Louis Wiseman been licensed in?
Dmand AI has state licenses on file for Dr. Wiseman in California (1971 to 2026), Florida (2016 to 2018), Texas (1973 to 1980) and Louisiana (1974 to 1975).
Where did Dr. Charles Louis Wiseman go to medical school?
Dr. Wiseman graduated from David Geffen School of Medicine at UCLA in 1969.
What drugs does Dr. Charles Louis Wiseman prescribe most?
In 2020 Medicare Part D data, Dr. Wiseman's most prescribed drugs by claims were Voriconazole.
Has Dr. Charles Louis Wiseman received payments from drug or device companies?
CMS Open Payments shows $1,246 in general payments to Dr. Wiseman from 14 companies from 2016 to 2020. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Charles Louis Wiseman been practicing?
Dr. Wiseman graduated from medical school in 1969, 57 years ago.
Does Dr. Charles Louis Wiseman do research?
Dmand AI links 22 publications to Dr. Wiseman, published from 2003 to 2018. Dr. Wiseman has worked on 2 clinical trials.
Who does Dr. Charles Louis Wiseman publish with?
Dr. Wiseman's most frequent co-authors are Cary A. Presant, MD (7 shared papers), Douglas W. Blayney, MD (6 shared papers) and George R. Blumenschein, MD (4 shared papers).
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card